Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 421, 678 (13 February 2003) | doi:10.1038/421678b
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
- More Challenges
- Powered by:
nature jobs
Senior Analyst - SCI
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Postdoctoral Positions
- Meharry Medical College
- Nashville, Tennessee, USA
Cancer fears cast doubts on future of gene therapy
Erika Check
A once-promising gene-therapy treatment should be used only as a last resort, advisers to the US National Institutes of Health (NIH) said this week.Members of the NIH's Recombinant DNA Advisory Committee, meeting in Bethesda, Maryland, on 10 February, said that patients suffering from severe combined immunodeficiency disease (SCID) should be treated by gene therapy only if they fail to respond to all other treatments.
To read this story in full you will need to login or make a payment (see right).
